China Health Group Limited (carrying on business in Hong Kong as CHG HS Limited) has filed a civil appeal dated 3 June 2026 with the Chengde Intermediate People’s Court, challenging the Civil Judgment served on 21 May 2026 in its ongoing litigation.

The company has paid the case-acceptance fee on 6 July 2026 and is now appealing to the Higher People’s Court of Hebei Province. Key requests in the appeal include:

1. Revocation of the original Civil Judgment. 2. Reversion of the judgment to fully uphold the company’s original first-instance claims. 3. An order that the defendants jointly bear all litigation costs for both the first- and second-instance proceedings.

China Health Group argues that the Chengde Intermediate Court erred in determining key facts, omitted critical evidence, and misapplied relevant laws. The appeal aims to protect the legitimate rights and interests of the company and its shareholders.

Management stated that further announcements will be made should there be any material developments. Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares.